March 20, 2013
News Office: Leland Kim (415) 502-6397
Heidi Dohse has spent much of her adulthood monitoring a pacemaker implanted into her chest at the age of 19 to repair arrhythmias, or rapid irregular heartbeats.
For years, that's meant that Dohse, 49, has had to fly several times a year from her New York home to California for check-ups with the medical team at UC San Francisco that performed the life-saving procedure to correct her heart rhythms when she was a teenager.
Those time-consuming trips are no longer as necessary since she's enrolled in an ambitious UCSF-developed online cardiovascular study that harnesses the power of mobile technology to monitor patients using their smartphones and send the information to doctors who can analyze the data and provide instant feedback.
"Because I live in New York and my UCSF doctors are here in San Francisco, I can use all these mobile devices and tools to feel like I'm still a patient of theirs," Dohse said. "It's one of the reasons my staying with UCSF makes sense."
Through the Health eHeart Study, which launched Tuesday, physicians hope to better understand how the heart functions and to develop new ways to predict and prevent cardiovascular disease. The study — funded by the Salesforce.com Foundation — aims to enroll 1 million people from around the world.
"We hope to be able to collect copious amounts of data on a large segment of the population so we can develop very robust and accurate models to predict the occurrence of heart disease in people who don't yet have heart disease, or slow the progression in people who already have heart disease," said cardiac electrophysiologist Dr. Jeffrey Olgin, chief of the UCSF Division of Cardiology.
A major goal of the Health eHeart Study is to make health care delivery more precise. The study allows participants to submit data via a secure online survey and uses smartphone technology to measure a participant's heart rate, blood pressure and pulse rate. The information is sent back to researchers, who can make recommendations to help prevent or treat heart disease.
Jeffrey Olgin, M.D.
The concept of precision medicine — which emerged from a 2010 National Academy of Sciences report co-authored by UCSF Chancellor Dr. Susan Desmond-Hellmann and Dr. Charles Sawyers, of Memorial Sloan-Kettering Cancer Center — is to transform medical care worldwide by integrating the wealth of data emerging from both the human genome and research on the molecular basis of disease, with information from patients' health records and environmental data. It has become a driving vision for UCSF, which is convening a summit in May to create a roadmap for precision medicine nationwide.
"With this platform, we hope to be able to diagnose and treat heart patients more rapidly than is currently done with traditional research, since we'll have a large patient population," Olgin said. "And because these patients are connected to us electronically and through their smartphones, we can deploy the study very quickly."
Heart disease is the leading cause of death in America for men and women, killing approximately 600,000 people, more than all types of cancer and AIDS combined, according to the Centers for Disease Control and Prevention. One in three adults — or 82 million Americans — have heart disease, and every minute a person dies of a heart attack. Coronary heart disease alone costs the United States $108.9 billion each year in health services, medications and lost productivity.
"Most people aren't aware that one out of four deaths in America is due to heart disease," Olgin said. "And a third of people who have cardiovascular disease aren't even aware of their risks. That's why the 'Health eHeart Study' is so important."
To say that Dohse enjoyed sports as a child would be an understatement. She began swimming at the age of 6. Her youth was filled with soccer, tennis, cross country, track and snow skiing. In her 20s, she became a professional windsurfer, traveling the world competing in events.
"Both my sister and brother played sports, and our parents were very much involved in our sports," she said. "I honestly wanted to be a little princess and take ballet, but I ended up playing sports instead — which, it turns out, saved my life."
Dohse learned about her arrhythmia at the age of 18 when she got her first EKG at the doctor's office while getting some cartilage fragments removed from her knee.
To correct her severe heart condition, she underwent one of the first procedures at UCSF to restore normal heart rhythms called AV (atrioventricular) node ablation, which modifies the electrical pathway that connects the top chambers of the heart to its bottom chambers. Doctors also implanted a pacemaker, a small device placed in the chest that uses electrical pulses to help the heart beat at a normal rate.
Her condition hasn't stopped her from staying active, and the instant feedback from the Health eHeart Study helps keep Dohse within a safe range whenever she goes on a grueling training ride.
"That's one of the hardest thing to do as a heart patient is wonder what's going on? What's happening in there? Is it a flutter I need to worry about? Is it an episode? Or did I just imagine that?" said Dohse, who uses a Boston Scientific heart rate monitor that does not have a chest strap, and an AliveCor iPhone case that allows her to take EKGs from her smartphone.
"Now with this study, not only are they collecting my data, they're also collecting data of people like me, that will create specific heart plans for me now," she added. "And this is going to help guide treatments as I get older, as I go through different phases of my heart care, so I'm really excited about participating and adding my data to the pool, but also learning and taking advantage of what's learned from everybody else."
The apps and certain study-related devices are free to participants. Olgin and his team plan to analyze the data to identify patterns. This will allow them to not only identify "population-based" predictors, but also to identify deviations from baselines.
The Health eHeart Study expands on the Framingham Heart Study, which tracked 5,209 men and women in Framingham, Mass., starting in 1948.
The study, under the direction of the National Heart, Lung and Blood Institute, tracked three generations of participants between the ages of 30 and 62. Some had symptoms of cardiovascular disease; others did not.
The Framingham Heart Study established research milestones by finding that:
"The Framingham model tracked participants in one city," Olgin said. "Imagine that model on a global scale and taking the collected data to treat heart patients so precisely that we can account for their gender, age, ethnicity and lifestyle factors."
Olgin is the lead researcher of this study; co-researchers include Dr. Gregory Marcus of the UCSF Division of Cardiology; and Dr. Mark J. Pletcher of the UCSF Department of Epidemiology and Biostatistics.
Mobile phone usage in the United States has grown exponentially. Currently the United States has approximately 322 million mobile phone users, and of that, almost half (49.7 percent) are smart phone users, according to the Nielsen Company. That's more than 314 million, the number of people actually living in the United States, according to the U.S. Census Bureau.
By 2016, the number of smartphone users is expected to more than double. Globally, more than 6 billion people, or about 87 percent of the world population, are mobile phone users, and there is at least one cellphone subscription per person in the developed world, according to a report by the International Telecommunication Union.
Dohse can now accurately monitor her heart with mobile technology in real time and make sure she stays in a safe range whenever she goes on a 206-mile single-day bike race through three states and three mountain passes.
"I learned at a very young age to appreciate every single day, and I don't think it's a gift everyone is given," Dohse said. "The doctors at UCSF and this new study allow me to have an amazing life versus having an OK life being a victim on the couch."
About UCSF Medical Center
UCSF Medical Center consistently ranks as one of the top 10 hospitals in the United States. Recognized for innovative treatments, advanced technology, collaboration among health care professionals and scientists, and a highly compassionate patient care team, UCSF Medical Center serves as the academic medical center of the University of California, San Francisco. The medical center's nationally preeminent programs include children's health, the brain and nervous system, organ transplantation, women's health and cancer. It operates as a self-supporting enterprise within UCSF and generates its own revenues to cover the operating costs of providing patient care.
This news release has been modified for the website